Jed_Jones.pdf (169.83 kB)
Patient and public understanding of the concept of ‘personalised medicine’ in relation to cancer treatment: a systematic review
journal contribution
posted on 2023-06-10, 03:34 authored by Jed Botham, Valerie ShillingValerie Shilling, John JonesJohn JonesPersonalised medicine (PM) is becoming increasingly integrated into standard clinical practice for treating numerous diseases, including cancer. Implementing PM into healthcare systems will only be successful with the acceptance and input of both patients’ and public opinion. This review, therefore, aimed to identify both patients’ and public understanding, and perceived benefits and concerns of PM in cancer treatment. A literature search was conducted using MEDLINE, EMBASE, PsycINFO and CINAHL databases. The eligibility criteria specified that papers must explore the public or patients’ understanding of PM or pharmacogenomic (PGx) testing in relation to cancer treatment. Patients have a greater understanding of, and trust in, PM compared with members of the public, but often misunderstand how genomic testing in PM works. Key areas that can be targeted to inform future health literacy interventions include genetic literacy for the public and understanding of how PM testing and treatment works for patients.
History
Publication status
- Published
File Version
- Published version
Journal
Future Healthcare JournalISSN
2514-6645Publisher
Royal College of PhysiciansExternal DOI
Issue
3Volume
8Article number
e703-e708Department affiliated with
- Clinical and Experimental Medicine Publications
Full text available
- Yes
Peer reviewed?
- Yes